Table 1.
Baseline health-related quality of life
| FCM (n= 304) | Placebo (n= 155) | |
|---|---|---|
| HRQoL: EQ-5D | ||
| Visual analogue scale | ||
| Missing data, n (%) | 9 (3) | 3 (2) |
| Mean ± SEM | 54 ± 1 | 54 ± 1 |
| Index score (×100) | ||
| Missing data, n (%) | 6 (2) | 1 (1) |
| Mean ± SEM | 68 ± 1 | 69 ± 1 |
| Patients reporting any problem by domain | ||
| Mobility, n (%) | 245 (81) | 131 (85) |
| Self-care, n (%) | 146 (49) | 79 (51) |
| Usual activity, n (%) | 232 (77) | 124 (81) |
| Pain/discomfort, n (%) | 228 (76) | 117 (75) |
| Anxiety/depression, n (%) | 194 (65) | 97 (63) |
| HRQoL: KCCQ | ||
| Missing data, n (%) | 7 (2) | 4 (3) |
| Overall summary score, mean ± SEM | 52 ± 1 | 53 ± 1 |
| Clinical summary score, mean ± SEM | 55 ± 1 | 55 ± 1 |
| Total symptom score, mean ± SEM | 59 ± 1 | 59 ± 2 |
| Physical limitation, mean ± SEM | 52 ± 1 | 52 ± 2 |
| Symptom burden, mean ± SEM | 59 ± 1 | 60 ± 1 |
| Symptom frequency, mean ± SEM | 59 ± 1 | 58 ± 2 |
| Symptom stability, mean ± SEM | 54 ± 1 | 53 ± 1 |
| Self-efficacy, mean ± SEM | 64 ± 1 | 63 ± 2 |
| Quality of life, mean ± SEM | 47 ± 1 | 48 ± 2 |
| Social limitation, mean ± SEM | 51 ± 2 | 51 ± 2 |
Visual Analogue Scale and Kansas City Cardiomyopathy Questionnaire overall summary score data were previously published, and are included here for context.16
KCCQ, Kansas City Cardiomyopathy Questionnaire.